# Sergio Aguirre

> Sergio Aguirre is the founder and CEO of EchoPixel, a Silicon Valley medical imaging company that turns standard CT, MRI and ultrasound scans into interactive 3D holograms doctors can grab, rotate and dissect in open space. An electrical engineer from Tecnologico de Monterrey with a graduate focus on stereoscopic imaging, he spent more than 15 years in visualization systems before founding EchoPixel in 2012. His True3D platform earned FDA clearance and has been used in congenital heart defect detection and structural heart procedures, built on his conviction that doctors should not have to solve a 3D problem with a 2D picture.

- **Role:** Founder & CEO at EchoPixel, Inc.
- **Organizations:** EchoPixel, Inc., Innouva Technologies de Mexico SA de CV
- **Nationality:** Mexican
- **Education:** M.Sc. in Electronics, focus on Image Processing and Stereoscopic Imaging, Tecnologico de Monterrey (ITESM), B.Sc. in Electrical Engineering, Tecnologico de Monterrey (ITESM)
- **Known for:** Founded EchoPixel and built True3D, an FDA-cleared interactive 3D/holographic medical visualization platform, Enabled detection of up to 90% more congenital heart defects in newborns in clinical evaluation, Reduced medical device (e.g. stent) sizing time from about 40 minutes to roughly 2 minutes

## Career timeline

- **2000** — Became CEO of Innouva Technologies de Mexico SA de CV (through 2005)
- **2012** — Founded EchoPixel to bring interactive 3D visualization to medical imaging
- **2016** — EchoPixel raised a $5.8M seed round; True3D featured by TechCrunch
- **2016** — True3D received FDA clearance for holographic visualization from CT and MRI data
- **2018** — EchoPixel graduated from Fogarty Innovation
- **2019** — Introduced first-ever intraoperative software for 3D holographic support of structural heart procedures at TCT 2019

## Achievements

- Founded EchoPixel and built True3D, an FDA-cleared interactive 3D/holographic medical visualization platform
- Enabled detection of up to 90% more congenital heart defects in newborns in clinical evaluation
- Reduced medical device (e.g. stent) sizing time from about 40 minutes to roughly 2 minutes
- Delivered the first-ever intraoperative 3D holographic software to support structural heart procedures (TCT 2019)
- Pioneer with 15+ years in stereoscopic 3D and visualization systems
- Led EchoPixel through Fogarty Innovation and a Series A stage of growth

## Latest updates

- **2019-09** — EchoPixel introduced first-ever intraoperative software for 3D holographic support of structural heart procedures at TCT 2019.

## Links

- Website: https://echopixeltech.com
- LinkedIn: http://www.linkedin.com/in/sergioaguirrevalencia
- Twitter/X: https://twitter.com/echopixel_inc
- Facebook: https://facebook.com/echopixeltech/

---

Profile page: https://yespress.io/sergio-aguirre
Published by YesPress — https://yespress.io
Last updated: 2026-07-29